Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dengue virus infections.

Benedito Antônio Lopes da Fonseca1, Silvia Nunes Szente Fonseca

  • 1Departamento de Clinica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil. baldfons@fmrp.usp.br

Current Opinion in Pediatrics
|March 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Yellow Fever Virus Surveillance in Callithrix spp. Marmosets during Epizootic Outbreak, Brazil, 2024-2025.

Emerging infectious diseases·2026
Same author

Maturation-deficient chikungunya virus elicits protective immune responses in a murine challenge model.

NPJ vaccines·2026
Same author

Prolonged Evaluation of COVID-19 Vaccine Effectiveness in Healthcare Workers at a Public Tertiary Hospital: A Retrospective Cohort Study.

Revista da Sociedade Brasileira de Medicina Tropical·2026
Same author

Yellow fever virus resurgence in Sao Paulo State, Brazil, 2024-2025.

Revista do Instituto de Medicina Tropical de Sao Paulo·2026
Same author

Botulism type C outbreak in free-ranging wild birds in a public urban park in Ribeirão Preto, São Paulo state, Brazil.

Open veterinary journal·2025
Same author

Corrigendum to Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study.

Vaccine: X·2025

Dengue fever, a significant arbovirus disease, affects over 2.5 billion people globally. Current control relies on vector management as no specific treatments or vaccines are available.

Area of Science:

  • * Medical Entomology
  • * Infectious Diseases
  • * Public Health

Background:

  • * Dengue is a major global arbovirus disease, endemic in over 100 countries, posing a risk to 2.5 billion people.
  • * Infections range from asymptomatic to severe dengue hemorrhagic fever/dengue shock syndrome.
  • * Caused by four dengue virus serotypes and transmitted primarily by Aedes aegypti mosquitoes.

Purpose of the Study:

  • * To highlight the public health significance of dengue infections.
  • * To underscore the current limitations in dengue management and prevention.
  • * To emphasize the ongoing need for research in diagnosis and vaccine development.

Main Methods:

  • * Review of existing literature on dengue epidemiology, virology, and clinical manifestations.

Related Experiment Videos

  • * Analysis of current public health strategies for dengue control.
  • * Identification of knowledge gaps in dengue diagnosis and vaccine development.

    • Main Results:

    • * Dengue virus poses a significant global health threat, with widespread geographic distribution and high-risk populations.
    • * Clinical presentations vary widely, from mild febrile illness to life-threatening hemorrhagic conditions.
    • * Effective vector control remains the primary strategy due to the absence of specific antiviral treatments and licensed vaccines.

    Conclusions:

    • * Dengue remains a critical public health challenge requiring enhanced surveillance and control measures.
    • * The lack of specific medical countermeasures necessitates continued research into novel therapeutic and prophylactic interventions.
    • * Further advancements in diagnostic tools and vaccine development are crucial for mitigating the global impact of dengue.